In debating the right and wrong of public hospitals cooking up copies of approved nuclear medicine therapies, this country must contemplate the broader consequences, including of any funding decision. …
Funding unapproved copies would fundamentally change our system - it can't be allowed to happen
October 16, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
OncoSil Medical completes recruitment in TRIPP-FFX clinical trial
July 23, 2025 - - Australian Biotech -
Nyrada advances Xolatryp towards Phase 2a trial in cardioprotection
July 23, 2025 - - Australian Biotech -
Amplia Therapeutics announces $25 million placement and launches share purchase plan
July 23, 2025 - - Australian Biotech -
Percheron Therapeutics announces publication of new preclinical HMBD-002 data
July 23, 2025 - - Australian Biotech -
US leads the way on cell and gene therapy with new rapid access program
July 23, 2025 - - Latest News -
Neuraxpharm continues international expansion with launch of Australian affiliate
July 23, 2025 - - Latest News -
Companies secure certification as 'Great Places to Work'
July 23, 2025 - - Latest News